Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective, three-arm, randomized, open-label trial to determine if a new pain
control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine
for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces
average pain scores.
Phase:
Phase 4
Details
Lead Sponsor:
AdventHealth Florida Hospital
Collaborators:
Sagent Pharmaceuticals Inc. Sagent Pharmaceuticals, Inc.